nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—Medroxyprogesterone Acetate—Methylprednisolone—ankylosing spondylitis	0.24	1	CrCrCtD
Cyproterone acetate—NR3C1—Methylprednisolone—ankylosing spondylitis	0.123	0.194	CbGbCtD
Cyproterone acetate—NR3C1—Triamcinolone—ankylosing spondylitis	0.0933	0.147	CbGbCtD
Cyproterone acetate—CYP19A1—Betamethasone—ankylosing spondylitis	0.0881	0.139	CbGbCtD
Cyproterone acetate—NR3C1—Betamethasone—ankylosing spondylitis	0.08	0.126	CbGbCtD
Cyproterone acetate—NR3C1—Prednisolone—ankylosing spondylitis	0.079	0.124	CbGbCtD
Cyproterone acetate—NR3C1—Prednisone—ankylosing spondylitis	0.0746	0.117	CbGbCtD
Cyproterone acetate—CYP19A1—Dexamethasone—ankylosing spondylitis	0.0513	0.0806	CbGbCtD
Cyproterone acetate—NR3C1—Dexamethasone—ankylosing spondylitis	0.0466	0.0732	CbGbCtD
Cyproterone acetate—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000166	0.00134	CcSEcCtD
Cyproterone acetate—Mood swings—Methotrexate—ankylosing spondylitis	0.000166	0.00134	CcSEcCtD
Cyproterone acetate—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000166	0.00133	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000165	0.00133	CcSEcCtD
Cyproterone acetate—Weight increased—Prednisone—ankylosing spondylitis	0.000165	0.00133	CcSEcCtD
Cyproterone acetate—Weight decreased—Prednisone—ankylosing spondylitis	0.000164	0.00132	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.000164	0.00132	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.000162	0.0013	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000162	0.0013	CcSEcCtD
Cyproterone acetate—Visual impairment—Dexamethasone—ankylosing spondylitis	0.000161	0.00129	CcSEcCtD
Cyproterone acetate—Visual impairment—Betamethasone—ankylosing spondylitis	0.000161	0.00129	CcSEcCtD
Cyproterone acetate—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000161	0.00129	CcSEcCtD
Cyproterone acetate—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00016	0.00128	CcSEcCtD
Cyproterone acetate—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.00016	0.00128	CcSEcCtD
Cyproterone acetate—Myocardial infarction—Prednisone—ankylosing spondylitis	0.000159	0.00128	CcSEcCtD
Cyproterone acetate—Breast disorder—Methotrexate—ankylosing spondylitis	0.000159	0.00128	CcSEcCtD
Cyproterone acetate—Malaise—Prednisolone—ankylosing spondylitis	0.000157	0.00126	CcSEcCtD
Cyproterone acetate—Syncope—Prednisolone—ankylosing spondylitis	0.000156	0.00126	CcSEcCtD
Cyproterone acetate—Eye disorder—Betamethasone—ankylosing spondylitis	0.000156	0.00125	CcSEcCtD
Cyproterone acetate—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000156	0.00125	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000153	0.00123	CcSEcCtD
Cyproterone acetate—Asthma—Methotrexate—ankylosing spondylitis	0.000152	0.00122	CcSEcCtD
Cyproterone acetate—Angiopathy—Betamethasone—ankylosing spondylitis	0.000151	0.00122	CcSEcCtD
Cyproterone acetate—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000151	0.00122	CcSEcCtD
Cyproterone acetate—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000149	0.0012	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000149	0.00119	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000148	0.00119	CcSEcCtD
Cyproterone acetate—Alopecia—Dexamethasone—ankylosing spondylitis	0.000147	0.00119	CcSEcCtD
Cyproterone acetate—Alopecia—Betamethasone—ankylosing spondylitis	0.000147	0.00119	CcSEcCtD
Cyproterone acetate—Discomfort—Prednisolone—ankylosing spondylitis	0.000146	0.00118	CcSEcCtD
Cyproterone acetate—Haemoglobin—Prednisone—ankylosing spondylitis	0.000146	0.00117	CcSEcCtD
Cyproterone acetate—Haemorrhage—Prednisone—ankylosing spondylitis	0.000145	0.00117	CcSEcCtD
Cyproterone acetate—Malaise—Triamcinolone—ankylosing spondylitis	0.000144	0.00116	CcSEcCtD
Cyproterone acetate—Malaise—Methylprednisolone—ankylosing spondylitis	0.000144	0.00116	CcSEcCtD
Cyproterone acetate—Syncope—Triamcinolone—ankylosing spondylitis	0.000144	0.00115	CcSEcCtD
Cyproterone acetate—Syncope—Methylprednisolone—ankylosing spondylitis	0.000143	0.00115	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000143	0.00115	CcSEcCtD
Cyproterone acetate—Oedema—Prednisolone—ankylosing spondylitis	0.000142	0.00114	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000141	0.00113	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00014	0.00113	CcSEcCtD
Cyproterone acetate—Shock—Prednisolone—ankylosing spondylitis	0.00014	0.00112	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00014	0.00112	CcSEcCtD
Cyproterone acetate—Cough—Triamcinolone—ankylosing spondylitis	0.00014	0.00112	CcSEcCtD
Cyproterone acetate—Tachycardia—Prednisolone—ankylosing spondylitis	0.000139	0.00112	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000138	0.00111	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000137	0.0011	CcSEcCtD
Cyproterone acetate—Eye disorder—Prednisone—ankylosing spondylitis	0.000136	0.00109	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000135	0.00109	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000135	0.00108	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000135	0.00108	CcSEcCtD
Cyproterone acetate—Discomfort—Triamcinolone—ankylosing spondylitis	0.000135	0.00108	CcSEcCtD
Cyproterone acetate—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000134	0.00108	CcSEcCtD
Cyproterone acetate—Renal failure—Methotrexate—ankylosing spondylitis	0.000133	0.00107	CcSEcCtD
Cyproterone acetate—Angiopathy—Prednisone—ankylosing spondylitis	0.000132	0.00106	CcSEcCtD
Cyproterone acetate—Immune system disorder—Prednisone—ankylosing spondylitis	0.000131	0.00106	CcSEcCtD
Cyproterone acetate—Malaise—Betamethasone—ankylosing spondylitis	0.000131	0.00105	CcSEcCtD
Cyproterone acetate—Malaise—Dexamethasone—ankylosing spondylitis	0.000131	0.00105	CcSEcCtD
Cyproterone acetate—Oedema—Triamcinolone—ankylosing spondylitis	0.000131	0.00105	CcSEcCtD
Cyproterone acetate—Syncope—Betamethasone—ankylosing spondylitis	0.00013	0.00105	CcSEcCtD
Cyproterone acetate—Syncope—Dexamethasone—ankylosing spondylitis	0.00013	0.00105	CcSEcCtD
Cyproterone acetate—Sweating—Methotrexate—ankylosing spondylitis	0.00013	0.00104	CcSEcCtD
Cyproterone acetate—Haematuria—Methotrexate—ankylosing spondylitis	0.000129	0.00104	CcSEcCtD
Cyproterone acetate—Shock—Triamcinolone—ankylosing spondylitis	0.000129	0.00103	CcSEcCtD
Cyproterone acetate—Alopecia—Prednisone—ankylosing spondylitis	0.000128	0.00103	CcSEcCtD
Cyproterone acetate—Shock—Methylprednisolone—ankylosing spondylitis	0.000128	0.00103	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000128	0.00103	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000128	0.00103	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000128	0.00103	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000128	0.00103	CcSEcCtD
Cyproterone acetate—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000128	0.00103	CcSEcCtD
Cyproterone acetate—Mental disorder—Prednisone—ankylosing spondylitis	0.000127	0.00102	CcSEcCtD
Cyproterone acetate—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000127	0.00102	CcSEcCtD
Cyproterone acetate—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000127	0.00102	CcSEcCtD
Cyproterone acetate—Malnutrition—Prednisone—ankylosing spondylitis	0.000127	0.00102	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000126	0.00102	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000126	0.00101	CcSEcCtD
Cyproterone acetate—Discomfort—Dexamethasone—ankylosing spondylitis	0.000122	0.000983	CcSEcCtD
Cyproterone acetate—Discomfort—Betamethasone—ankylosing spondylitis	0.000122	0.000983	CcSEcCtD
Cyproterone acetate—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000122	0.000982	CcSEcCtD
Cyproterone acetate—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000122	0.00098	CcSEcCtD
Cyproterone acetate—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000121	0.000977	CcSEcCtD
Cyproterone acetate—Hepatitis—Methotrexate—ankylosing spondylitis	0.000121	0.000977	CcSEcCtD
Cyproterone acetate—Oedema—Dexamethasone—ankylosing spondylitis	0.000119	0.000953	CcSEcCtD
Cyproterone acetate—Oedema—Betamethasone—ankylosing spondylitis	0.000119	0.000953	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000117	0.000944	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000117	0.000942	CcSEcCtD
Cyproterone acetate—Visual impairment—Methotrexate—ankylosing spondylitis	0.000117	0.000941	CcSEcCtD
Cyproterone acetate—Anaemia—Prednisone—ankylosing spondylitis	0.000117	0.00094	CcSEcCtD
Cyproterone acetate—Shock—Betamethasone—ankylosing spondylitis	0.000117	0.000938	CcSEcCtD
Cyproterone acetate—Shock—Dexamethasone—ankylosing spondylitis	0.000117	0.000938	CcSEcCtD
Cyproterone acetate—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000116	0.000937	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000116	0.000935	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000116	0.000935	CcSEcCtD
Cyproterone acetate—Agitation—Prednisone—ankylosing spondylitis	0.000116	0.000935	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000116	0.000934	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000116	0.000934	CcSEcCtD
Cyproterone acetate—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000116	0.000931	CcSEcCtD
Cyproterone acetate—Tachycardia—Betamethasone—ankylosing spondylitis	0.000116	0.000931	CcSEcCtD
Cyproterone acetate—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000115	0.000925	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000115	0.000924	CcSEcCtD
Cyproterone acetate—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000115	0.000923	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000115	0.000922	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000115	0.000922	CcSEcCtD
Cyproterone acetate—Malaise—Prednisone—ankylosing spondylitis	0.000114	0.000917	CcSEcCtD
Cyproterone acetate—Eye disorder—Methotrexate—ankylosing spondylitis	0.000113	0.000913	CcSEcCtD
Cyproterone acetate—Syncope—Prednisone—ankylosing spondylitis	0.000113	0.000912	CcSEcCtD
Cyproterone acetate—Anorexia—Dexamethasone—ankylosing spondylitis	0.000113	0.000909	CcSEcCtD
Cyproterone acetate—Anorexia—Betamethasone—ankylosing spondylitis	0.000113	0.000909	CcSEcCtD
Cyproterone acetate—Urticaria—Prednisolone—ankylosing spondylitis	0.000113	0.000908	CcSEcCtD
Cyproterone acetate—Fatigue—Triamcinolone—ankylosing spondylitis	0.000113	0.000906	CcSEcCtD
Cyproterone acetate—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000112	0.000904	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000111	0.000894	CcSEcCtD
Cyproterone acetate—Hypotension—Betamethasone—ankylosing spondylitis	0.000111	0.000891	CcSEcCtD
Cyproterone acetate—Hypotension—Dexamethasone—ankylosing spondylitis	0.000111	0.000891	CcSEcCtD
Cyproterone acetate—Angiopathy—Methotrexate—ankylosing spondylitis	0.00011	0.000886	CcSEcCtD
Cyproterone acetate—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00011	0.000882	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000109	0.00088	CcSEcCtD
Cyproterone acetate—Chills—Methotrexate—ankylosing spondylitis	0.000109	0.000876	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000108	0.000866	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000107	0.000864	CcSEcCtD
Cyproterone acetate—Alopecia—Methotrexate—ankylosing spondylitis	0.000107	0.000863	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000107	0.00086	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000107	0.000857	CcSEcCtD
Cyproterone acetate—Discomfort—Prednisone—ankylosing spondylitis	0.000106	0.000856	CcSEcCtD
Cyproterone acetate—Mental disorder—Methotrexate—ankylosing spondylitis	0.000106	0.000856	CcSEcCtD
Cyproterone acetate—Malnutrition—Methotrexate—ankylosing spondylitis	0.000106	0.00085	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000105	0.000842	CcSEcCtD
Cyproterone acetate—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000104	0.000839	CcSEcCtD
Cyproterone acetate—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000104	0.000839	CcSEcCtD
Cyproterone acetate—Urticaria—Triamcinolone—ankylosing spondylitis	0.000104	0.000835	CcSEcCtD
Cyproterone acetate—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000104	0.000833	CcSEcCtD
Cyproterone acetate—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000103	0.000831	CcSEcCtD
Cyproterone acetate—Oedema—Prednisone—ankylosing spondylitis	0.000103	0.00083	CcSEcCtD
Cyproterone acetate—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000103	0.000829	CcSEcCtD
Cyproterone acetate—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000103	0.000829	CcSEcCtD
Cyproterone acetate—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000103	0.000829	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000102	0.000823	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000102	0.000823	CcSEcCtD
Cyproterone acetate—Fatigue—Dexamethasone—ankylosing spondylitis	0.000102	0.000822	CcSEcCtD
Cyproterone acetate—Fatigue—Betamethasone—ankylosing spondylitis	0.000102	0.000822	CcSEcCtD
Cyproterone acetate—Shock—Prednisone—ankylosing spondylitis	0.000102	0.000817	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000101	0.000814	CcSEcCtD
Cyproterone acetate—Tachycardia—Prednisone—ankylosing spondylitis	0.000101	0.00081	CcSEcCtD
Cyproterone acetate—Skin disorder—Prednisone—ankylosing spondylitis	0.0001	0.000807	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Prednisone—ankylosing spondylitis	9.98e-05	0.000803	CcSEcCtD
Cyproterone acetate—Anorexia—Prednisone—ankylosing spondylitis	9.84e-05	0.000791	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Methotrexate—ankylosing spondylitis	9.81e-05	0.000789	CcSEcCtD
Cyproterone acetate—Anaemia—Methotrexate—ankylosing spondylitis	9.77e-05	0.000786	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Dexamethasone—ankylosing spondylitis	9.77e-05	0.000786	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Betamethasone—ankylosing spondylitis	9.77e-05	0.000786	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	9.69e-05	0.00078	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	9.69e-05	0.00078	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Triamcinolone—ankylosing spondylitis	9.63e-05	0.000774	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	9.61e-05	0.000772	CcSEcCtD
Cyproterone acetate—Malaise—Methotrexate—ankylosing spondylitis	9.53e-05	0.000767	CcSEcCtD
Cyproterone acetate—Leukopenia—Methotrexate—ankylosing spondylitis	9.46e-05	0.000761	CcSEcCtD
Cyproterone acetate—Urticaria—Dexamethasone—ankylosing spondylitis	9.42e-05	0.000757	CcSEcCtD
Cyproterone acetate—Urticaria—Betamethasone—ankylosing spondylitis	9.42e-05	0.000757	CcSEcCtD
Cyproterone acetate—Dizziness—Prednisolone—ankylosing spondylitis	9.4e-05	0.000756	CcSEcCtD
Cyproterone acetate—Asthenia—Triamcinolone—ankylosing spondylitis	9.37e-05	0.000754	CcSEcCtD
Cyproterone acetate—Abdominal pain—Dexamethasone—ankylosing spondylitis	9.37e-05	0.000754	CcSEcCtD
Cyproterone acetate—Abdominal pain—Betamethasone—ankylosing spondylitis	9.37e-05	0.000754	CcSEcCtD
Cyproterone acetate—Body temperature increased—Betamethasone—ankylosing spondylitis	9.37e-05	0.000754	CcSEcCtD
Cyproterone acetate—Body temperature increased—Dexamethasone—ankylosing spondylitis	9.37e-05	0.000754	CcSEcCtD
Cyproterone acetate—Asthenia—Methylprednisolone—ankylosing spondylitis	9.35e-05	0.000752	CcSEcCtD
Cyproterone acetate—Pruritus—Triamcinolone—ankylosing spondylitis	9.24e-05	0.000743	CcSEcCtD
Cyproterone acetate—Cough—Methotrexate—ankylosing spondylitis	9.23e-05	0.000742	CcSEcCtD
Cyproterone acetate—Pruritus—Methylprednisolone—ankylosing spondylitis	9.22e-05	0.000742	CcSEcCtD
Cyproterone acetate—Dyspepsia—Prednisone—ankylosing spondylitis	9.09e-05	0.000731	CcSEcCtD
Cyproterone acetate—Decreased appetite—Prednisone—ankylosing spondylitis	8.98e-05	0.000722	CcSEcCtD
Cyproterone acetate—Rash—Prednisolone—ankylosing spondylitis	8.96e-05	0.00072	CcSEcCtD
Cyproterone acetate—Dermatitis—Prednisolone—ankylosing spondylitis	8.95e-05	0.00072	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	8.94e-05	0.000719	CcSEcCtD
Cyproterone acetate—Diarrhoea—Methylprednisolone—ankylosing spondylitis	8.92e-05	0.000717	CcSEcCtD
Cyproterone acetate—Fatigue—Prednisone—ankylosing spondylitis	8.9e-05	0.000716	CcSEcCtD
Cyproterone acetate—Headache—Prednisolone—ankylosing spondylitis	8.9e-05	0.000716	CcSEcCtD
Cyproterone acetate—Discomfort—Methotrexate—ankylosing spondylitis	8.89e-05	0.000715	CcSEcCtD
Cyproterone acetate—Constipation—Prednisone—ankylosing spondylitis	8.83e-05	0.00071	CcSEcCtD
Cyproterone acetate—Dizziness—Triamcinolone—ankylosing spondylitis	8.64e-05	0.000695	CcSEcCtD
Cyproterone acetate—Dizziness—Methylprednisolone—ankylosing spondylitis	8.62e-05	0.000693	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Prednisone—ankylosing spondylitis	8.51e-05	0.000684	CcSEcCtD
Cyproterone acetate—Asthenia—Betamethasone—ankylosing spondylitis	8.51e-05	0.000684	CcSEcCtD
Cyproterone acetate—Asthenia—Dexamethasone—ankylosing spondylitis	8.51e-05	0.000684	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Methotrexate—ankylosing spondylitis	8.46e-05	0.000681	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Methotrexate—ankylosing spondylitis	8.45e-05	0.000679	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Prednisone—ankylosing spondylitis	8.44e-05	0.000679	CcSEcCtD
Cyproterone acetate—Nausea—Prednisolone—ankylosing spondylitis	8.44e-05	0.000679	CcSEcCtD
Cyproterone acetate—Pruritus—Betamethasone—ankylosing spondylitis	8.39e-05	0.000675	CcSEcCtD
Cyproterone acetate—Pruritus—Dexamethasone—ankylosing spondylitis	8.39e-05	0.000675	CcSEcCtD
Cyproterone acetate—Skin disorder—Methotrexate—ankylosing spondylitis	8.38e-05	0.000674	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Methotrexate—ankylosing spondylitis	8.34e-05	0.000671	CcSEcCtD
Cyproterone acetate—Vomiting—Triamcinolone—ankylosing spondylitis	8.31e-05	0.000668	CcSEcCtD
Cyproterone acetate—Vomiting—Methylprednisolone—ankylosing spondylitis	8.29e-05	0.000667	CcSEcCtD
Cyproterone acetate—Rash—Triamcinolone—ankylosing spondylitis	8.24e-05	0.000663	CcSEcCtD
Cyproterone acetate—Dermatitis—Triamcinolone—ankylosing spondylitis	8.23e-05	0.000662	CcSEcCtD
Cyproterone acetate—Anorexia—Methotrexate—ankylosing spondylitis	8.22e-05	0.000661	CcSEcCtD
Cyproterone acetate—Rash—Methylprednisolone—ankylosing spondylitis	8.22e-05	0.000661	CcSEcCtD
Cyproterone acetate—Dermatitis—Methylprednisolone—ankylosing spondylitis	8.21e-05	0.00066	CcSEcCtD
Cyproterone acetate—Urticaria—Prednisone—ankylosing spondylitis	8.2e-05	0.00066	CcSEcCtD
Cyproterone acetate—Headache—Triamcinolone—ankylosing spondylitis	8.19e-05	0.000658	CcSEcCtD
Cyproterone acetate—Headache—Methylprednisolone—ankylosing spondylitis	8.17e-05	0.000657	CcSEcCtD
Cyproterone acetate—Abdominal pain—Prednisone—ankylosing spondylitis	8.16e-05	0.000656	CcSEcCtD
Cyproterone acetate—Body temperature increased—Prednisone—ankylosing spondylitis	8.16e-05	0.000656	CcSEcCtD
Cyproterone acetate—Diarrhoea—Betamethasone—ankylosing spondylitis	8.11e-05	0.000652	CcSEcCtD
Cyproterone acetate—Diarrhoea—Dexamethasone—ankylosing spondylitis	8.11e-05	0.000652	CcSEcCtD
Cyproterone acetate—Hypotension—Methotrexate—ankylosing spondylitis	8.06e-05	0.000648	CcSEcCtD
Cyproterone acetate—Dizziness—Dexamethasone—ankylosing spondylitis	7.84e-05	0.000631	CcSEcCtD
Cyproterone acetate—Dizziness—Betamethasone—ankylosing spondylitis	7.84e-05	0.000631	CcSEcCtD
Cyproterone acetate—Nausea—Triamcinolone—ankylosing spondylitis	7.76e-05	0.000624	CcSEcCtD
Cyproterone acetate—Nausea—Methylprednisolone—ankylosing spondylitis	7.74e-05	0.000623	CcSEcCtD
Cyproterone acetate—Dyspnoea—Methotrexate—ankylosing spondylitis	7.69e-05	0.000619	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Prednisone—ankylosing spondylitis	7.61e-05	0.000612	CcSEcCtD
Cyproterone acetate—Dyspepsia—Methotrexate—ankylosing spondylitis	7.6e-05	0.000611	CcSEcCtD
Cyproterone acetate—Vomiting—Dexamethasone—ankylosing spondylitis	7.54e-05	0.000606	CcSEcCtD
Cyproterone acetate—Vomiting—Betamethasone—ankylosing spondylitis	7.54e-05	0.000606	CcSEcCtD
Cyproterone acetate—Decreased appetite—Methotrexate—ankylosing spondylitis	7.5e-05	0.000603	CcSEcCtD
Cyproterone acetate—Rash—Betamethasone—ankylosing spondylitis	7.48e-05	0.000601	CcSEcCtD
Cyproterone acetate—Rash—Dexamethasone—ankylosing spondylitis	7.48e-05	0.000601	CcSEcCtD
Cyproterone acetate—Dermatitis—Dexamethasone—ankylosing spondylitis	7.47e-05	0.000601	CcSEcCtD
Cyproterone acetate—Dermatitis—Betamethasone—ankylosing spondylitis	7.47e-05	0.000601	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	7.45e-05	0.000599	CcSEcCtD
Cyproterone acetate—Fatigue—Methotrexate—ankylosing spondylitis	7.44e-05	0.000598	CcSEcCtD
Cyproterone acetate—Headache—Dexamethasone—ankylosing spondylitis	7.43e-05	0.000597	CcSEcCtD
Cyproterone acetate—Headache—Betamethasone—ankylosing spondylitis	7.43e-05	0.000597	CcSEcCtD
Cyproterone acetate—Asthenia—Prednisone—ankylosing spondylitis	7.41e-05	0.000596	CcSEcCtD
Cyproterone acetate—Pruritus—Prednisone—ankylosing spondylitis	7.3e-05	0.000587	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Methotrexate—ankylosing spondylitis	7.11e-05	0.000572	CcSEcCtD
Cyproterone acetate—Diarrhoea—Prednisone—ankylosing spondylitis	7.06e-05	0.000568	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	7.06e-05	0.000567	CcSEcCtD
Cyproterone acetate—Nausea—Dexamethasone—ankylosing spondylitis	7.04e-05	0.000566	CcSEcCtD
Cyproterone acetate—Nausea—Betamethasone—ankylosing spondylitis	7.04e-05	0.000566	CcSEcCtD
Cyproterone acetate—Urticaria—Methotrexate—ankylosing spondylitis	6.85e-05	0.000551	CcSEcCtD
Cyproterone acetate—Dizziness—Prednisone—ankylosing spondylitis	6.83e-05	0.000549	CcSEcCtD
Cyproterone acetate—Abdominal pain—Methotrexate—ankylosing spondylitis	6.82e-05	0.000549	CcSEcCtD
Cyproterone acetate—Body temperature increased—Methotrexate—ankylosing spondylitis	6.82e-05	0.000549	CcSEcCtD
Cyproterone acetate—Vomiting—Prednisone—ankylosing spondylitis	6.56e-05	0.000528	CcSEcCtD
Cyproterone acetate—Rash—Prednisone—ankylosing spondylitis	6.51e-05	0.000524	CcSEcCtD
Cyproterone acetate—Dermatitis—Prednisone—ankylosing spondylitis	6.5e-05	0.000523	CcSEcCtD
Cyproterone acetate—Headache—Prednisone—ankylosing spondylitis	6.47e-05	0.00052	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Methotrexate—ankylosing spondylitis	6.36e-05	0.000511	CcSEcCtD
Cyproterone acetate—Asthenia—Methotrexate—ankylosing spondylitis	6.19e-05	0.000498	CcSEcCtD
Cyproterone acetate—Nausea—Prednisone—ankylosing spondylitis	6.13e-05	0.000493	CcSEcCtD
Cyproterone acetate—Pruritus—Methotrexate—ankylosing spondylitis	6.1e-05	0.000491	CcSEcCtD
Cyproterone acetate—Diarrhoea—Methotrexate—ankylosing spondylitis	5.9e-05	0.000475	CcSEcCtD
Cyproterone acetate—Dizziness—Methotrexate—ankylosing spondylitis	5.71e-05	0.000459	CcSEcCtD
Cyproterone acetate—Vomiting—Methotrexate—ankylosing spondylitis	5.49e-05	0.000441	CcSEcCtD
Cyproterone acetate—Rash—Methotrexate—ankylosing spondylitis	5.44e-05	0.000438	CcSEcCtD
Cyproterone acetate—Dermatitis—Methotrexate—ankylosing spondylitis	5.44e-05	0.000437	CcSEcCtD
Cyproterone acetate—Headache—Methotrexate—ankylosing spondylitis	5.41e-05	0.000435	CcSEcCtD
Cyproterone acetate—Nausea—Methotrexate—ankylosing spondylitis	5.13e-05	0.000412	CcSEcCtD
